Obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is though to affect around 4% of the male and 2% of the female population of North America. Continuous positive airway pressure (CPAP) particularly for moderate to severe cases. The aim of this cross-over trial was to compare the two types of mandibular advancement appliances (MAAs) with different structures, retention [read the full story…]
Obstructive sleep apnoea syndrome (OSAS) affects about 4% of the male and 2% of the female population of North America. Standard treatment is with continuous positive airway pressure (CPAP) however this has poor adherence in some groups and oral appliance therapy is an alternative therapy. The aim of this trial was to assess variations in [read the full story…]
This is a critical summary prepared by ADA Centre for Evidence-Based Dentistry of a systematic review originally published in 2010. The original review looked at which surgical modifications of the upper airway were most effective in reducing the apnoea-hypopnoea index (AHI) for patietns suffering with obstructive sleep apnoea (OSA). OSA is relatively common occurring in [read the full story…]
Randomized controlled trials have previously addressed the efficacy of mandibular advancement devices (MADs) in the treatment of obstructive sleep apnoea (OSA). The control used in these studies is usually nasal continuous positive airway pressure (nCPAP). It is frequently found to be superior to MAD therapy. In most of these studies nCPAP was titrated objectively but [read the full story…]
